Hugel Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hugel Inc with three other
companies in this sector in South Korea:
Choong Ang Vaccine Laboratory
sales of 37.90 billion Korean Won [US$35.63 million]
Medy Tox Inc
(133.26 billion Korean Won [US$125.26 million]
of which 100%
was Biological), and
Cell Biotech Co ., Limited.
(58.28 billion Korean Won [US$54.78 million]
of which 88%
was Finished Products).